M-Pharma SRL
The score of M-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -98 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
M-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2020 | |
|---|---|---|---|---|---|
| Net result | −11,138 € | ||||
| Equity | −242,824 € | ||||
| Cash | 3,503 € | ||||
| EBITDA | −10,655 € | ||||
| Total assets | 5,948 € |
Filed annual accounts
- Year ended 28 Dec 2025filed on 09 Oct 2026
- Year ended 31 Dec 2024filed on 22 Sep 2025
- Year ended 01 Jan 2023filed on 22 Aug 2023
- Year ended 02 Jan 2022filed on 08 Aug 2022
- Year ended 27 Dec 2020filed on 20 Aug 2021
M-Pharma's financial analysis
- Solvency-4082.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of M-Pharma
M-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0678.937.543
- VAT number
- BE0678937543
- Peppol
- Registered · 0208:0678937543 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jul 2017
- Registered office
- 2600 Antwerp
- Latest accounts
- 2025 · filed on 09 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
M-Pharma (SRL) has been based in Antwerp since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,138 € and equity of −242,824 €; its revenue is not published. Its solvency stands at -4082.4%, below the median of its sector (44.2%).
Companies similar to M-Pharma
Companies in the same business, of comparable size and area, outside its group.
- LA Pharmacie DU Parc Retail sale of pharmaceutical products Grez-Doiceau · balance sheet 210,632 €
- Apoteek't Groen Kruis Retail sale of pharmaceutical products Schoten · balance sheet 220,163 €
- Apotheek Bisschoppenhof Retail sale of pharmaceutical products Antwerp · balance sheet 200,383 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
- Genaphar Retail sale of pharmaceutical products Brussels · balance sheet 147,330 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Cornut C Retail sale of pharmaceutical products Mons · balance sheet 43,250 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
Frequently asked questions about M-Pharma
What is the revenue of M-Pharma?
M-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of M-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0678937543 for M-Pharma, if the company is VAT-registered. Its company number (CBE) is 0678.937.543.
Where is the registered office of M-Pharma?
According to the CBE register, the registered office of M-Pharma is in 2600 Antwerp.
What is the equity of M-Pharma?
At the close of the 2025 financial year, the equity of M-Pharma amounts to -242,824 €, a solvency of -4082.4% of total assets.
Who manages M-Pharma?
The register lists 3 active mandates at M-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of M-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →